Dimerix

Dimerix Shares Outstanding

The The number of shares of Dimerix (DXB.AX) as of Nov 13, 2026 is 560.42 M. In the previous year, The number of shares was 560.42 M — a change of 0.00% (lower).

Shares Outstanding

560.42 M

YoY

0.00%

Last updated:

In 2026, Dimerix had 560.42 M outstanding stocks, a 0.00% change from the 560.42 M stocks in the previous year.

The Dimerix Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2022
560.42 M AUD
Jan 1, 2023
560.42 M AUD
Jan 1, 2024
560.42 M AUD
Jan 1, 2025
560.42 M AUD
Jan 1, 2026
560.42 M AUD
Jan 1, 2027 (e)
600.40 AUD
Jan 1, 2028 (e)
600.40 AUD
Jan 1, 2029 (e)
600.40 AUD
The Dimerix Shares Outstanding history
YEARShares OutstandingYoY
est600.400.00%
est600.400.00%
est600.40-100.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M0.00%
560.42 M+3.17 B%
17.69+30.77%
13.53+30.00%
10.41+0.00%
10.410.00%
10.41+90.89%
5.45+32.75%
4.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Number of shares

Dimerix shares outstanding

The number of shares of Dimerix was 600.26 M in 2025. This indicates how many shares Dimerix is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
326.57 M Stocks
Jan 1, 2023
405.74 M Stocks
Jan 1, 2024
554.76 M Stocks
Jan 1, 2025
600.26 M Stocks
Jan 1, 2026
600.40 M Stocks
Jan 1, 2027 (e)
600.40 M Stocks
Jan 1, 2028 (e)
600.40 M Stocks
Jan 1, 2029 (e)
600.40 M Stocks

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Dimerix's Shares Outstanding

Dimerix's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Dimerix’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Dimerix’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Dimerix’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Dimerix stock

The number of shares of Dimerix is 560.42 M in 2026.

The number of shares of Dimerix changed from 560.42 M to 560.42 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Dimerix since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Dimerix

All Key Metrics — Dimerix